5060.0: Wednesday, November 15, 2000: 8:30 AM-10:00 AM | ||||
| ||||
| Medications for the treatment of Attention Deficit-Hyperactivity Disorder(ADHD) diagnosis greatly increased in their use in the 1990s. Methylphenidate (Ritalin)production increased by 700%. Amphetamine production has tripled over the past three years. The United States uses 85% of the world's stimulants. Stimulant use rates vary widely within the United States, between the individual states, individual communities, economic,ethnic and racial groups. Whether stimulants are over or under prescribed depends upon the diagnostic and medication threshholds for that community. The presenters will offer data demonstrating what's known about the varying rates of diagnosis and treatment of ADHD. The economic, social and cultural factors involved in the diagnosis and treatment of ADHD will be explored | ||||
| See individual abstracts for presenting author's disclosure statement. | ||||
| Learning Objectives: Refer to the individual abstracts for learning objectives | ||||
| Gretchen B. Lefever, PhD | ||||
| Gretchen B. LeFever, PhD | ||||
| Parental Concerns Regarding Stimulant Treatment for ADHD Susan dosReis, PhD, Julie M. Zito, PhD, Daniel J. Safer, MD | ||||
| Sociocultural Determinants of Stimulant Prescription to Children: Prevalence in Primary School Youths in Quebec and France David Cohen, PhD | ||||
| Trends in Stimulants for the Treatment of ADHD Julie M. Zito, PhD, Daniel J. Safer, MD, Susan dosReis, PhD, J Gardner | ||||
| Understanding ADHD Issues in a Community with a High ADHD Prevalence Rate: Parent, Teacher, and Provider Perspectives Gretchen B. LeFever, PhD, Joanne L. Parker, MPH, Ardythe L. Morrow, PhD, Margaret S. Villers | ||||
| Sponsor: | Mental Health | |||
| Cosponsors: | Disability Forum; Epidemiology; Medical Care; School Health Education and Services; Social Work; Socialist Caucus | |||